FDA Approved: CARBAMAZEPINE ER — Supplemental Application (Bostal LLC)

View source ↗

Summary

FDA approved a supplemental application for Carbamazepine ER submitted by Bostal LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy
• Trigeminal Neuralgia

Drugs mentioned

• Carbamazepine ER (carbamazepine)

Snippet

SUPPL AP for CARBAMAZEPINE ER (CARBAMAZEPINE)